MENU
UNCY
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Unicycive Therapeutics (UNCY) Ownership - Who owns Unicycive Therapeutics?

Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions... Show more

Profile

Industry
N/A
Address
4300 El Camino Real
Phone
+1 650 351-4495
Employees
14
Web
https://www.unicycive.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
52.22M
P/E Ratio
N/A
Total Cash
26.14M
Projected Growth
N/A
Total Debt
694K
Revenue
N/A
Risk (Beta)
2.05
Dividend Yield
N/A
Total Cash/Share
2.05
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

UNCY
Capitalization
52.2M
P/E Ratio
N/A
Risk (Beta)
2.05
Dividend Yield
N/A
Total Cash
26.1M
Total Cash/Share
2.05
Total Debt
694K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
11.3M
P/B Ratio
4.63
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
120K
Current Ratio
1.64
Current Revenue Per Employee
56250.00
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
35.1M
Shares Outstanding - Current
12.8M
Total Liabilities
16.7M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-48.502
View a ticker or compare two or three
UNCY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. UNCY showed earnings on May 14, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
4300 El Camino Real
Phone
+1 650 351-4495
Employees
14
Web
https://www.unicycive.com